{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:13:30Z","timestamp":1790036010194,"version":"4.0.1"},"reference-count":84,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/17474086.2022.2098105","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:25:56Z","timestamp":1656998756000},"page":"583-595","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Fedratinib, the first selective JAK2 inhibitor approved for treatment of myelofibrosis \u2013 an option beyond ruxolitinib"],"prefix":"10.1080","volume":"15","author":[{"given":"Chandan","family":"Saha","sequence":"first","affiliation":[{"name":"Department of Hematology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24592"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S212559"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1177\/1179545X17695233"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.552"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-486050"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-018879"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-578435"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-671172"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679571"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0954-2"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01205-x"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0612"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30088-1"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.148"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-783225"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1590"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.02.009"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.02.017"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8021"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000954"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404955"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0644-4"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170449"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.63"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222944"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.218"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-03929-9"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04131-y"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04102-3"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04074-4"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04121-0"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04084-2"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000553"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25777"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000562"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18207"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.204602"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-81"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.161"},{"key":"cit0046","unstructured":"Fedratinib. LiverTox Clin. Res. Inf. Drug-Induced Liver Inj. 2012."},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2020.1852263"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.850"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0417-z"},{"key":"cit0050","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2017-05-785790","volume":"130","author":"Harrison CN","year":"2017","journal-title":"Blood"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14128"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0167-3"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147607"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00526-z"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.84"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001426"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00506"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-488098"},{"key":"cit0059","unstructured":"Ruxolotinib. Summary of product characteristics. Bristol Myers Squibb Receives European Commission Approval for Inrebic\u00ae (fedratinib) for adult patients with newly diagnosed and previously treated myelofibrosis. [cited 2022 Mar 17]. https:\/\/www.medicines.org.uk\/emc\/product\/7786"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194750"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01032-0"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116289"},{"key":"cit0063","unstructured":"Press release. August 2021 https:\/\/news.bms.com\/news\/details\/2021\/Bristol-Myers-Squibb-Receives-European-Commission-Approval-for-Inrebic-fedratinib-for-Adult-Patients-with-Newly-Diagnosed-and-Previously-Treated-Myelofibrosis\/default.aspx."},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(21)01822-X"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.06.025"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33541"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S267001"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00438-4"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.03.005"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1038\/s41432-020-0105-7"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-020-00126-5"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2021.100755"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030130"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01214"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100634"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3007"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16684"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109799"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002662"},{"key":"cit0080","unstructured":"Press release. Sierra oncology announces momelotinib achieved statistically significant benefit on symptoms, anemia and splenic size in the pivotal momentum study for myelofibrosis. [cited 2022 Mar 17]. https:\/\/investor.sierraoncology.com\/news-releases\/news-details\/2022\/Sierr."},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02246"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5818"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30027-3"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.7002"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2022.2098105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T10:17:05Z","timestamp":1659781025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2022.2098105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,3]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/17474086.2022.2098105"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2022.2098105","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}